Bioxytran Statistics

Total Valuation

Bioxytran has a market cap or net worth of 14.41 million. The enterprise value is 15.54 million.

Market Cap	14.41M
Enterprise Value	15.54M

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Bioxytran has 88.88 million shares outstanding. The number of shares has increased by 3.45% in one year.

Current Share Class	n/a
Shares Outstanding	88.88M
Shares Change (YoY)	+3.45%
Shares Change (QoQ)	-26.47%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	n/a
Float	88.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-8.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.57
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.90

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1,002.88%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	124.50%
Revenue Per Employee	n/a
Profits Per Employee	-788,894
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.43% in the last 52 weeks. The beta is 1.00, so Bioxytran's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+18.43%
50-Day Moving Average	0.14
200-Day Moving Average	0.11
Relative Strength Index (RSI)	51.46
Average Volume (20 Days)	168,981

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.23M
Pretax Income	-2.38M
Net Income	-2.37M
EBITDA	-2.22M
EBIT	-2.23M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 5,154 in cash and 1.09 million in debt, giving a net cash position of -1.09 million or -0.01 per share.

Cash & Cash Equivalents	5,154
Total Debt	1.09M
Net Cash	-1.09M
Net Cash Per Share	-0.01
Equity (Book Value)	-1.79M
Book Value Per Share	-0.02
Working Capital	-1.93M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-55,737
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioxytran does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.45%
Shareholder Yield	-3.45%
Earnings Yield	-16.43%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a